Anand Kumar Singh

Anand Kumar Singh

Auto-generated profile, based on publicly available information

Anand Kumar Singh

Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
ASAnand Kumar Singh
Anand Kumar Singh
MTManindra Nath Tiwari
Manindra Nath Tiwari
OPOm Prakash
Om Prakash
MSMahendra Pratap Singh
Mahendra Pratap Singh
Cypermethrin, a class II pyrethroid pesticide, is used to control insects in the household and agricultural fields. Despite beneficial roles, its uncontrolled and repetitive applications lead to unintended effects in non-target organisms. Cypermethrin crosses the blood-brain barrier and induces neurotoxicity and motor deficits. Cypermethrin prolongs the opening of sodium channel, a major site of its action, leading to hyper-excitation of the central nervous system. In addition to sodium channel, cypermethrin modulates chloride, voltage-gated calcium and potassium channels, alters the activity of glutamate and acetylcholine receptors and adenosine triphosphatases and induces DNA damage and oxidative stress in the neuronal cells. Cypermethrin also modulates the level of neurotransmitters, including gamma-aminobutyric acid and dopamine. It is one of the most commonly used pesticides in neurotoxicology research not only because of its variable responses depending upon the doses, time and routes of exposure and strain, age, gender and species of animals used across multiple studies but also owing to its ability to induce the nigrostriatal dopaminergic neurodegeneration. This article describes the effect of acute, chronic, developmental and adulthood exposures to cypermethrin in experimental animals. The article sheds light on cypermethrin-induced changes in the central nervous system, including its contribution in the onset of specific features, which are associated with the nigrostriatal dopaminergic neurodegeneration. Resemblances and dissimilarities of cypermethrin-induced nigrostriatal dopaminergic neurodegeneration with sporadic and chemicals-induced disease models along with its advantages and pitfalls are also discussed.

1 February 2012 in Neurobiology of Aging
Verified
Journal Article
Closed access
ASAnand Kumar Singh
Anand Kumar Singh
MTManindra Nath Tiwari
Manindra Nath Tiwari
GUGhanshyam Upadhyay
Ghanshyam Upadhyay
DPDevendra Kumar Patel
Devendra Kumar Patel
DSDhirendra Singh
Dhirendra Singh
MSMahendra Pratap Singh
Mahendra Pratap Singh

21 December 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MFMichael Fritz
Michael Fritz
AKAnna M. Klawonn
Anna M. Klawonn
ANAnna Nilsson
Anna Nilsson
ASAnand Kumar Singh
Anand Kumar Singh
JZJoanna Zajdel
Joanna Zajdel
DEDavid Engblom
David Engblom
Systemic inflammation causes malaise and general feelings of discomfort. This fundamental aspect of the sickness response reduces the quality of life for people suffering from chronic inflammatory diseases and is a nuisance during mild infections like common colds or the flu. To investigate how inflammation is perceived as unpleasant and causes negative affect, we used a behavioral test in which mice avoid an environment that they have learned to associate with inflammation-induced discomfort. Using a combination of cell-type–specific gene deletions, pharmacology, and chemogenetics, we found that systemic inflammation triggered aversion through MyD88-dependent activation of the brain endothelium followed by COX1-mediated cerebral prostaglandin E2 (PGE2) synthesis. Further, we showed that inflammation-induced PGE2 targeted EP1 receptors on striatal dopamine D1 receptor–expressing neurons and that this signaling sequence induced aversion through GABA-mediated inhibition of dopaminergic cells. Finally, we demonstrated that inflammation-induced aversion was not an indirect consequence of fever or anorexia but that it constituted an independent inflammatory symptom triggered by a unique molecular mechanism. Collectively, these findings demonstrate that PGE2-mediated modulation of the dopaminergic motivational circuitry is a key mechanism underlying the negative affect induced by inflammation.

9 May 2010 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
SGSatya Prakash Gupta
Satya Prakash Gupta
SPSuman Patel
Suman Patel
SYSharawan Yadav
Sharawan Yadav
ASAnand Kumar Singh
Anand Kumar Singh
SSSeema Singh
Seema Singh
MSMahendra Pratap Singh
Mahendra Pratap Singh

1 October 2008 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GUGhanshyam Upadhyay
Ghanshyam Upadhyay
ASAnand Kumar Singh
Anand Kumar Singh
AKAbhai Kumar
Abhai Kumar
OPOm Prakash
Om Prakash
MSMahendra Pratap Singh
Mahendra Pratap Singh

10 May 2011 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
ASAnand Kumar Singh
Anand Kumar Singh
MTManindra Nath Tiwari
Manindra Nath Tiwari
ADAnubhuti Dixit
Anubhuti Dixit
GUGhanshyam Upadhyay
Ghanshyam Upadhyay
DPDevendra Kumar Patel
Devendra Kumar Patel
MSMahendra Pratap Singh
Mahendra Pratap Singh
The study aimed to identify the differentially expressed nigrostriatal proteins in cypermethrin-induced neurodegeneration and to investigate the role of microglial activation therein. Proteomic approaches were used to identify the differentially expressed proteins. Microglial activation, tyrosine hydroxylase immunoreactivity (TH-IR), dopamine content, and neurobehavioral changes were measured according to the standard procedures. The expressions of α-internexin intermediate filament (α-IIF), ATP synthase D chain (ATP-SD), heat shock protein (Hsp)-70, truncated connexin-47, Hsp-60, mitogen-activated protein kinase-activated kinase-5, nicotinamide adenine dinucleotide dehydrogenase 24k chain precursor, platelet-activating factor acetyl hydrolase 1b-α2 (PAF-AH 1b-α2), and synaptosomal-associated protein-25 (SNAP-25) were altered in the substantia nigra and nicotinamide adenine dinucleotide- specific isocitrate dehydrogenase, phosphatidylethanolamine-binding protein-1, prohibitin, protein disulfide isomerase-endoplasmic reticulum 60 protease, stathmin, and ubiquitin-conjugating enzyme in the striatum along with motor impairment, decreased dopamine and TH-IR, and increased microglial activation after cypermethrin exposure. Minocycline restored α-IIF, ATP-SD chain, truncated connexin-47, Hsp-60, PAF-AH 1b-α2, stathmin and SNAP-25 expressions, motor impairment, dopamine, TH-IR, and microglial activation. The results suggest that cypermethrin produces microglial activation-dependent and -independent changes in the expression patterns of the nigrostriatal proteins leading to dopaminergic neurodegeneration.